Biosimilar Drugs May Reduce U.S. Health Spending by $54 Billion Over Next Decade

Introducing“biosimilar” versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut health care spending in the United States by $54 billion over the next decade.

Source: RAND - October 23, 2017 Category: Health Management Authors: RAND Corporation Source Type: news